Q2 2024 Earnings Estimate for Biogen Inc. Issued By Wedbush (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities researchers at Wedbush reduced their Q2 2024 earnings per share estimates for shares of Biogen in a note issued to investors on Wednesday, April 24th. Wedbush analyst L. Chico now anticipates that the biotechnology company will earn $3.43 per share for the quarter, down from their prior […]

Related Keywords

Germany ,Illinois ,United States ,Piper Sandler ,Erick Rowinsky ,Priya Singhal ,Biogen Inc ,A Global Asset Management Inc ,Dynamic Advisor Solutions ,Boone Capital Management ,Biogen Company Profile ,Securities Exchange Commission ,Prudential Asset Management Co Ltd ,Illinois Municipal Retirement Fund ,Nasdaq ,Needham Company ,Jpmorgan Chase Co ,Free Report ,Get Free Report ,Asset Management Co Ltd ,Capital Management ,Global Asset Management ,Municipal Retirement Fund ,Advisor Solutions ,Exchange Commission ,Director Eric ,Biogen Daily ,Biogen ,Nasdaq Biib ,Biib ,Medical ,09062x10 ,Earnings Estimates ,Wedbush ,